ModiQuest Research BV, the Dutch antibody generation services company, today announced that it has entered into a research collaboration with the Beckman Research Institute of the City of Hope (“BRICOH”) aimed at the generation of novel monoclonal antibodies against a target selected by and proprietary to BRICOH. 

During the collaboration, ModiQuest will make use of its proprietary B-cell selection technology, ModiSelect^TM.  Financials details of the collaboration were not disclosed.

“We are delighted that the Beckman Research Institute of the City of Hope has selected ModiQuest Research as an antibody generation collaborator,” said Dr. Jos Raats, Managing Director of ModiQuest Research.  “This collaboration again demonstrates the value of our broad and unique technology platform for finding monoclonal antibodies against some of the most difficult antigen targets.”

more about ModiSelect

more about ModiQuest Research